KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $115.0 million.

  • Quest Diagnostics' Net Cash Flow fell 7667.34% to $115.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$328.0 million, marking a year-over-year decrease of 15281.8%. This contributed to the annual value of -$130.0 million for FY2024, which is 13504.04% down from last year.
  • Latest data reveals that Quest Diagnostics reported Net Cash Flow of $115.0 million as of Q3 2025, which was down 7667.34% from $127.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Net Cash Flow high stood at $543.0 million for Q4 2023, and its period low was -$670.0 million during Q2 2021.
  • Its 5-year average for Net Cash Flow is -$38.0 million, with a median of -$90.0 million in 2022.
  • In the last 5 years, Quest Diagnostics' Net Cash Flow tumbled by 32222.22% in 2022 and then surged by 280000.0% in 2024.
  • Quest Diagnostics' Net Cash Flow (Quarter) stood at -$115.0 million in 2021, then plummeted by 234.78% to -$385.0 million in 2022, then soared by 241.04% to $543.0 million in 2023, then plummeted by 138.31% to -$208.0 million in 2024, then skyrocketed by 155.29% to $115.0 million in 2025.
  • Its last three reported values are $115.0 million in Q3 2025, $127.0 million for Q2 2025, and -$362.0 million during Q1 2025.